Zenas BioPharma, Inc.
ZBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $320 | $57 | $67 |
| Short-Term Investments | $31 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $3 | $1 |
| Total Curr. Assets | $356 | $60 | $68 |
| Property Plant & Equip (Net) | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $13 | $7 | $4 |
| Total NC Assets | $14 | $8 | $6 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $370 | $68 | $75 |
| Liabilities | – | – | – |
| Payables | $17 | $5 | $6 |
| Short-Term Debt | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $39 | $17 | $19 |
| Total Curr. Liab. | $57 | $23 | $26 |
| LT Debt | $0 | $21 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $250 | $240 |
| Total NC Liab. | $0 | $271 | $241 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 |
| Total Liabilities | $58 | $294 | $267 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$387 | -$230 | -$193 |
| AOCI | $0 | $0 | -$0 |
| Other Equity | $700 | $5 | $1 |
| Total Equity | $312 | -$226 | -$192 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $370 | $68 | $75 |
| Net Debt | -$319 | -$36 | -$66 |